These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19961087)

  • 1. [Politics for conflicts of interest].
    Chabot JM
    Rev Prat; 2009 Nov; 59(9):1279-80. PubMed ID: 19961087
    [No Abstract]   [Full Text] [Related]  

  • 2. IOM: increase policing of conflicts of interest.
    Kuehn BM
    JAMA; 2009 May; 301(20):2083. PubMed ID: 19470980
    [No Abstract]   [Full Text] [Related]  

  • 3. IOM warns about physician-pharma conflicts of interest.
    Landers SJ; O'Reilly KB
    Del Med J; 2009 Jul; 81(7):261-3. PubMed ID: 19902777
    [No Abstract]   [Full Text] [Related]  

  • 4. Conflicts of interest. IOM panel backs public disclosure of drug company payments.
    Kaiser J
    Science; 2009 May; 324(5927):579. PubMed ID: 19407172
    [No Abstract]   [Full Text] [Related]  

  • 5. Conflicts of interest in medical education: recommendations from the Pew task force on medical conflicts of interest.
    Korn D; Carlat D
    JAMA; 2013 Dec; 310(22):2397-8. PubMed ID: 24327035
    [No Abstract]   [Full Text] [Related]  

  • 6. Congress responds to the IOM drug safety report--in full.
    Psaty BM; Korn D
    JAMA; 2007 Nov; 298(18):2185-7. PubMed ID: 18000202
    [No Abstract]   [Full Text] [Related]  

  • 7. Harmonizing reporting of financial conflicts.
    Kuehn BM
    JAMA; 2013 Jan; 309(1):19. PubMed ID: 23280201
    [No Abstract]   [Full Text] [Related]  

  • 8. Controlling conflict of interest--proposals from the Institute of Medicine.
    Steinbrook R
    N Engl J Med; 2009 May; 360(21):2160-3. PubMed ID: 19403898
    [No Abstract]   [Full Text] [Related]  

  • 9. Under the influence? IOM conflict-of-interest report raises concerns.
    Rhea S
    Mod Healthc; 2009 May; 39(18):8-9. PubMed ID: 19472501
    [No Abstract]   [Full Text] [Related]  

  • 10. CAM shock and awe.
    Hammerly M
    Health Forum J; 2003; 46(3):42. PubMed ID: 12942769
    [No Abstract]   [Full Text] [Related]  

  • 11. Can the Institute of Medicine review the FDA?
    Carroll BJ
    Nat Med; 2005 Apr; 11(4):369. PubMed ID: 15812509
    [No Abstract]   [Full Text] [Related]  

  • 12. Pragmatic and proportional analysis of conflict of interest.
    Bean S
    Am J Bioeth; 2011 Jan; 11(1):39-40. PubMed ID: 21240808
    [No Abstract]   [Full Text] [Related]  

  • 13. Relieving pain in America: insights from an Institute of Medicine committee.
    Dzau VJ; Pizzo PA
    JAMA; 2014 Oct; 312(15):1507-8. PubMed ID: 25321905
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to "Can the Institute of Medicine review the FDA?".
    Fineberg HV
    Nat Med; 2005 Jun; 11(6):589. PubMed ID: 15937463
    [No Abstract]   [Full Text] [Related]  

  • 15. Reflections from the National Mall.
    Ehlinger EP
    Minn Med; 2009 Feb; 92(2):34-5. PubMed ID: 19331287
    [No Abstract]   [Full Text] [Related]  

  • 16. The IOM-CAM roller coaster.
    Hammerly M
    Altern Ther Health Med; 2003; 9(4):16. PubMed ID: 12868247
    [No Abstract]   [Full Text] [Related]  

  • 17. The self-interest case for US global health cooperation.
    Lancet; 1997 Apr; 349(9058):1037. PubMed ID: 9107235
    [No Abstract]   [Full Text] [Related]  

  • 18. Dying in America and the world.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):335. PubMed ID: 25348231
    [No Abstract]   [Full Text] [Related]  

  • 19. Full disclosure.
    Angaran DM
    Am J Health Syst Pharm; 2007 Jun; 64(12):1331-3. PubMed ID: 17563057
    [No Abstract]   [Full Text] [Related]  

  • 20. Health care delivery errors: patient safety falls prey to politics.
    Shuren AW
    J Pediatr Health Care; 2001; 15(1):42-4. PubMed ID: 11174664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.